{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:24:48Z","timestamp":1792549488751,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"crossref","award":["HY-2011-G-201100000001880"],"award-info":[{"award-number":["HY-2011-G-201100000001880"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA 177932"],"award-info":[{"award-number":["CA 177932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jconrel.2017.03.028","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T08:16:15Z","timestamp":1489997775000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy"],"prefix":"10.1016","volume":"259","author":[{"given":"Eonju","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinWoo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YoonHo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Dong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.03.028_bb0005","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.biomaterials.2008.05.033","article-title":"Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy","volume":"29","author":"Hori","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0010","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0015","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1158\/0008-5472.CAN-05-3905","article-title":"Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients","volume":"66","author":"Wierecky","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0045(19970901)32:4<272::AID-PROS7>3.0.CO;2-L","article-title":"Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides","volume":"32","author":"Tjoa","year":"1997","journal-title":"Prostate"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0035","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00262-007-0325-0","article-title":"DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors","volume":"56","author":"Lim","year":"2007","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MPA.0b013e31822398c6","article-title":"Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and\/or S-1 in patients with advanced pancreatic carcinoma","volume":"41","author":"Kimura","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3892\/ol.2013.1376","article-title":"Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients","volume":"6","author":"Cui","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cytogfr.2007.01.014","article-title":"Cytokine gene transfer for cancer therapy","volume":"18","author":"Podhajcer","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0060","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0065","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1158\/1078-0432.CCR-06-0935","article-title":"Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model","volume":"12","author":"Lee","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0070","doi-asserted-by":"crossref","first-page":"e67512","DOI":"10.1371\/journal.pone.0067512","article-title":"Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-gamma- and TNF-alpha-co-producing T cell-mediated antitumor immunity","volume":"8","author":"Choi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0075","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/gt.2011.37","article-title":"Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rbeta2 or IL-18Ralpha","volume":"18","author":"Choi","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0080","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/gt.2011.125","article-title":"Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF","volume":"19","author":"Choi","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0085","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/mt.2009.205","article-title":"Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL","volume":"18","author":"Huang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0090","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/sj.gt.3302759","article-title":"Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect","volume":"13","author":"Choi","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0095","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/156652305774964712","article-title":"Gene therapy of cancer based on interleukin 12","volume":"5","author":"Sangro","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0100","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0105","first-page":"463","article-title":"Cytokine- and chemokine-based gene therapy for cancer","volume":"5","author":"Chada","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0110","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/jgm.800","article-title":"Oncolytic virotherapy for cancer treatment: challenges and solutions","volume":"7","author":"Davis","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0115","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jocn.2010.11.034","article-title":"A phase I\/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma","volume":"18","author":"Chang","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0120","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1002\/adfm.201401110","article-title":"Crosslinkable gelatin hydrogels for vasculogenic induction and delivery of mesenchymal stem cells","volume":"24","author":"Lee","year":"2014","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0125","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1039\/C4TB01111B","article-title":"Enzyme-catalyzed in situ forming gelatin hydrogels as bioactive wound dressings: effects of fibroblast delivery on wound healing efficacy","volume":"2","author":"Lee","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0130","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djj397","article-title":"Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy","volume":"98","author":"Kim","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00157684","article-title":"Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo","volume":"14","author":"Sawaya","year":"1996","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0140","doi-asserted-by":"crossref","first-page":"R326","DOI":"10.1186\/bcr1001","article-title":"Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency","volume":"7","author":"Gervais","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni0104-7","article-title":"Dendritic cells: a journey from laboratory to clinic","volume":"5","author":"Cerundolo","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0150","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1089\/hum.1997.8.14-1675","article-title":"Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","article-title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0160","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating Th1 immune responses","volume":"21","author":"Szabo","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0170","first-page":"89","article-title":"Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1","volume":"23","author":"Carrio","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0175","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1365-3083.2003.01206.x","article-title":"Cellular mechanism of thymic involution","volume":"57","author":"Li","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0180","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic cell-based immunotherapy: state of the art and beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.6.3.333","article-title":"Optimizing dendritic cell-based immunotherapy for cancer","volume":"6","author":"Zhong","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0190","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gt.2013.10","article-title":"Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy","volume":"20","author":"Choi","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0195","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.1997.8.9-1065","article-title":"Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells","volume":"8","author":"Yu","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0200","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1111\/j.1349-7006.2010.01704.x","article-title":"Antitumor effects of combined granulocyte macrophage colony stimulating factor and macrophage inflammatory protein-3 alpha plasmid DNA","volume":"101","author":"Choi","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0205","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.160.4.1666","article-title":"The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation","volume":"160","author":"de Saint-Vis","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.03.028_bb0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ijc.23962","article-title":"Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells","volume":"124","author":"Wehner","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0215","series-title":"Cancer Trial of Interleukin-12 Halted","author":"Marshall","year":"1995"},{"key":"10.1016\/j.jconrel.2017.03.028_bb0220","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4049\/jimmunol.159.5.2125","article-title":"A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma","volume":"159","author":"Ahn","year":"1997","journal-title":"J. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917301396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917301396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T18:31:23Z","timestamp":1692729083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917301396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":44,"alternative-id":["S0168365917301396"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.028","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}